Lipid Insights

How do we move the needle on cardiovascular prevention — not just in the clinic, but across entire systems and communities? In this episode of Lipid Insights, host Alan S. Brown, MD, MHA, MNLA sits down with Nihar R. Desai, MD, MPH, FNLA for a forward-thinking conversation on long-term LDL exposure and what it truly means to practice longevity medicine. From the power of imaging as a patient educa...

What does your patient's lipid panel actually tell you and what is it missing? In this special National Lipid Day episode of Lipid Insights, host Peter H. Jones, MD, MNLA, sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "The Lipid Doctor" — for a conversation that challenges some of medicine's most entrenched assumptions about lipid risk assessment. From the c...

In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Nivedita Patni, MD , of the Department of Pediatrics at UT Southwestern Medical Center in Dallas, TX, to explore the complex landscape of pediatric dyslipidemia. Dr. Patni walks through the critical importance of tailoring management to etiology, the long-term cardiovascular and metabolic risks that hang in the balance...

Childhood obesity is one of the most pressing public health challenges of our time — and its long-term cardiovascular and metabolic consequences make it essential territory for lipidologists and clinicians alike. In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Casey Berman, MD to explore the full picture: how childhood obesity is defined, why its prevalence continue...

Join host Dr. Peter H. Jones for a special episode of Lipid Insights discussing the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. Dr. Jones is joined by guideline author and NLA Past President Dr. Joseph Saseen and NLA President-Elect Dr. Dinesh Kalra to break down what clinicians need to know. From the restoration of LDL-C treatment goals and major conceptual shifts from...

In this episode of Lipid Insights, we explore the NLA's recent expert meta-analysis, "Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials."   Lead author Dinesh K. Kalra, MD, MBA and key author Kevin C. Maki, PhD, CLS, MNLA join host Alan S. Brown, MD, MHA, MNLA to examine the relationship between LDL-C reduction...

In this episode of Lipid Insights, host Dr. Peter Jones is joined by renowned experts Robert H. Eckel, MD, FNLA and Samuel M. Kim, MD for a thoughtful discussion on the complex relationship between obesity, weight loss, and cardiometabolic health. 

Hosted by Dave Dixon, PharmD, CLS, FNLA, this episode features an in-depth discussion with three key authors of the NLA’s new statement providing updated guidance on diagnosis, management, and treatment of FH. Together, they review the most important updates in the new guidance, including recommendations for earlier identification, the role of genetic testing and cascade screening, updated LDL-cho...

Dr. Peter Jones welcomes Dr. Nihar Desai for a forward-looking discussion on the future of cardiovascular prevention. From implementation science to performance measurement, this episode challenges traditional approaches and explores how innovation, systems thinking, and accountability can reshape how we achieve lasting cardiovascular health. Guest: Nihar R. Desai, MD, MPH Associate Professor of M...

In this episode of Lipid Insights , host Dr. Peter Jones is joined by Dr. Harold Bays for a practical, clinician-focused discussion of the ATTAIN Study and what it means for everyday lipid management. Together, they walk through the key questions clinicians ask when new evidence emerges: what the study set out to evaluate, how to interpret the findings in context, and where the results may (or may...

Join host Peter Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In this episode, Dr. Jones is joined by two leading pediatric experts— Don Wilson, MD, FNLA and Amy Shah, MD, FNLA —to explore practical strategies and emerging research on managing lipids and metabolic syndrome in younger populations. The discussion highlights key findings from their recentl...

Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed to equip clinicians with the latest evidence on Lp(a) biology, screening strategies, and current and emerging therapeutic options. Along with Drs. Soffer, Kulkarni and Wilkinson, they...

Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery disease may transform ASCVD prediction and management. Tune in and see what’s next in lipid science. Guest Host Daniel E. Soffer, MD, MNLA University of Penns...

In this episode of Lipid Insights, Dr. Peter Jones and guest Dr. Kevin Maki explore whether beef deserves its long-standing reputation as a driver of cardiovascular disease. Drawing on a recent systematic review and meta-analysis, they examine beef’s impact on cholesterol, blood pressure, and other key CVD risk factors—providing fresh perspective for clinicians navigating dietary guidance. This po...

In this short episode, guest host Dr. Dan Soffer chats with Dr. Joshua Hyman , the Young Investigator Award winner at #NLASessions 2025. Dr. Hyman gives a quick overview of his award-winning abstract and shares insights from his work in advancing lipid research.

Hosted by Dr. Dan Soffer, this conversation brings NLA President Dr. Willard and Beth Jackson together to unpack the Association’s guidance, “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better.” The trio turns a big message into practical moves: why lifetime LDL exposure matters, who needs more aggressive targets, and how to streamline therapy choices from high-intensity...

In this episode, Alan Brown, MD, MHA, MNLA sits down with Rebecca Juliano, PhD, MPhil, MA to discuss a first-in-human study of an investigational ANGPTL4 inhibitory antibody. The conversation explores how this novel therapeutic approach safely and effectively reduces plasma triglycerides and remnant cholesterol —key drivers of residual cardiovascular risk. Listeners will gain insight into the mech...

Explore the NLA’s new guidance on building effective, team-based approaches to improve outcomes in clinical lipidology and cardiometabolic care. Read the Expert Clinical Review HERE View this Episode on YouTube HERE Guest Host Daniel E. Soffer, MD, MNLA University of Pennsylvania Health System Internal Medicine/Clinical Lipidology Perelman Center for Advanced Medicine Philadelphia, PA Guests Mary...

Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific Sessions. Guest host Christie Ballantyne, MD, is joined by leading experts Seyedmohammad Saadatagah, MD, Erin Michos, MD, and Daniel Gaudet, MD, PhD, to break down key takeaways from the newly released Joint Expert Clinical Consensus from the National...